Effects of Pioglitazone on High-Fat-Diet–Induced Ventricular Remodeling and Dysfunction in Rats

Journal of Cardiovascular Pharmacology and Therapeutics - Tập 17 Số 2 - Trang 223-228 - 2012
Yaqiang Tian1,2, Shou-she LI3, Xudong Su1, Guangzhen Zhang1, Jiajun Zhao2, Guangwei Li4, Lexin Wang5
1Department of Endocrinology, Liaocheng People’s Hospital, Liaocheng, China
2Department of Endocrinology, Provincial Hospital affiliated to Shandong University, Jinan, China
3Department of Neurology, Liaocheng People’s Hospital, Liaocheng, China
4Department of Endocrinology, China–Japan Friendship Hospital, Beijing, China
5School of Biomedical Sciences and Centre for Inland Health, Charles Sturt University, Wagga Wagga, New South Wales, Australia

Tóm tắt

Objective: To investigate the effect of pioglitazone on high-fat (HF)-diet–induced left ventricular (LV) hypertrophy and dysfunction in rats. Methods: A total of 36 male Sprague-Dawley rats were randomly divided into 3 groups, namely, control, HF diet, and pioglitazone treatment group. High-fat diet group (HF group) animals were treated with HF diet for 30 weeks, whereas pioglitazone group was treated with HF diet for 30 weeks and pioglitazone in the last 6 weeks of the 30-week treatment. Fasting plasma free fatty acids (FFAs), serum, and myocardial triglyceride were measured. Left ventricular function was assessed by echocardiography. Renin, angiotensin II, and angiotensin types 1 and 2 (AT1/AT2) receptors in the myocardium were analyzed by immunohistochemistry and real-time polymerase chain reaction (PCR). Results: Systolic blood pressure, plasma FFA, serum, and myocardial triglyceride concentrations in HF group were higher than in control and pioglitazone groups ( P < .01). There was no significant difference in LV weight index and LV posterior wall thickness between HF and pioglitazone groups; both were higher than in the control group ( P < .01). Left ventricular ejection fraction, fraction of shortening, and cardiac index in HF group were lower than in the control and pioglitazone groups ( P < .05). Myocardial expression of angiotensin II and AT1 receptor protein in HF group was higher when compared with the control and pioglitazone groups ( P < .01). Myocardial renin and angiotensin II messenger RNA (mRNA) in HF group was also higher when compared with the control and pioglitazone groups, whereas the expression of AT2 mRNA was lower ( P < .01). Conclusion: Pioglitazone diminished HF-diet–induced LV dysfunction. These effects may be related to a reduction in blood pressure, myocardial triglycerides sedimentary, and suppression of renin–angiotensin system.

Từ khóa


Tài liệu tham khảo

10.1016/j.amjhyper.2005.07.024

Naour N, 1989, Int J Obes, 13, 95

10.1161/ATVBAHA.107.159228

10.1586/14779072.6.3.343

10.1056/NEJMoa072761

10.1016/j.carpath.2006.09.001

Kraegen EW, 1983, Am J Physiol, 245, E1, 10.1152/ajpcell.1983.245.1.C1

10.1016/S0021-9258(18)64849-5

10.1161/01.CIR.0000112379.88385.67

10.1056/NEJMoa020245

10.1016/j.amjcard.2005.02.031

10.1093/cvr/cvq313

10.1517/14740331003623218

10.1016/S0140-6736(05)67528-9

10.1016/j.abb.2008.05.015

10.1161/HYPERTENSIONAHA.107.099044

10.2310/6650.2007.00003

10.1172/JCI16751

10.1210/en.2003-0242

10.1210/en.2003-0870

10.2337/diabetes.53.7.1655

10.1073/pnas.97.4.1784

10.1161/CIRCULATIONAHA.105.536318

10.1172/JCI0214080

10.1073/pnas.97.2.931

10.1016/j.ejheart.2003.09.004

10.1161/01.CIR.0000031735.86021.79

10.1007/s00395-005-0528-5

10.1016/j.clinthera.2009.01.004

Thông tin
Thông tin xuất bản

Journal of Cardiovascular Pharmacology and Therapeutics

Tập 17 Số 2

223-228

Thông tin tác giả